Home > En > R and D > Publications > 2015

2015

Articles:

  • Cyclotron production of high purity 44m,44Sc with deuterons from 44CaCO3 targets Alliot C, Kerdjoudj R, Michel N, Haddad F, Huclier-Markai S. (2015) . Nucl Med Biol. 42: 524-529.
  • Is there an interest to use deuteron beams to produce non-conventional radionuclides? Alliot C, Audouin N, Barbet J, Bonraisin AC, Bossé V, Bourdeau C, Bourgeois M, Duchemin C, Guertin A, Haddad F, Huclier-Markai S, Kerdjoudj R, Laizé J, Métivier V, Michel N, Mokili M, Pageau M, Vidal A (2015) Frontiers in medicine, 2: 31.
  • Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients. Bodet-Milin C, Ferrer L, Rauscher A, Masson D, Rbah-Vidal L, Faivre-Chauvet A, Cerato E, Rousseau C, Hureaux J, Couturier O, Salaün PY, Goldenberg DM, Sharkey RM, Kraeber-Bodéré F, Barbet J (2015) Front Med (Lausanne), 2: 84.
  • Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging. Colombié M, Gouard S, Frindel M, Vidal A, Chérel M, Kraeber-Bodéré F, Rousseau C, Bourgeois M (2015) Front Med (Lausanne). 2: 58.
  • Production of scandium-44m and scandium-44g with deuterons on calcium-44: cross section measurements and production yield calculations. Duchemin C, Guertin A, Haddad F, Michel N, Metivier V (2015) Phys Med Biol, 60: 6847-6864.
  • Cross section measurements of deuteron induced nuclear reactions on natural titanium up to 34 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Metivier V (2015) Applied Radiat Isot, 103: 160-165.
  • Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Métivier V (2015) Phys Med Biol. 60: 931-946.
  • Cross section measurements of deuteron induced nuclear reactions on natural tungsten up to 34 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Métivier V. (2015) Appl Radiat Isot. 97: 52-58.
  • Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model. Fichou N, Gouard S, Maurel C, Barbet J, Ferrer L, Morgenstern A, Bruchertseifer F, Faivre-Chauvet A, Bigot-Corbel E, Davodeau F, Gaschet J, Chérel M (2015) Front Med (Lausanne), 2: 76.
  • Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy? Guérard F, Barbet J, Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F. (2015) Q J Nucl Med Mol Imaging. 59: 161-167. (IRON et ArronaxPlus)
  • A comparative thermodynamic study of the formation of scandium complexes with DTPA and DOTA, Huclier-Markai S, Alliot C, Sebti J, Brunel B, Aupiais J (2015) RSC Avances, 5: 99606-99617. (IRON, pas ArronaxPlus)
  • A pretargeting system for tumor PET imaging and radioimmunotherapy Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Frampas E, Faivre-Chauvet A, Rauscher A, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J. (2015) Front Pharmacol. 6: 54.
  • Radioimmunotherapy: from current clinical success to future industrial breakthrough? Kraeber-Bodéré F, Barbet J, Chatal JF (2015) J Nucl Med. 2015 Oct 29.
  • New beam monitoring tool for radiobiology experiments at the cyclotron ARRONAX. Schwob L, Koumeir C, Servagent N, Chérel M, Guertin A, Haddad F, Metivier V, Michel N, Poirier F, Rahmani A (2015) Radiat Prot Dosimetry, 166: 257-260.
  • Radiolytic corrosion of uranium dioxide induced by He2+ localized irradiation of water: Role of the produced H2O2 distance. Traboulsi A, Vandenborre J, Blain G, Humbert B, Haddad F, Fattahi M (2015) J Nucl Mat, 467: 832-839.